Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new areas for growth is much harder than for smaller, more agile players.
This is precisely where StockStory comes in - our job is to find you high-quality companies that can win regardless of the conditions. Keeping that in mind, here are three large-cap stocks whose competitive advantages create flywheel effects.
Copart (CPRT)
Market Cap: $31.29 billion
Starting as a single salvage yard in California in 1982, Copart (NASDAQ: CPRT) operates an online auction platform that connects sellers of damaged and salvage vehicles with buyers ranging from dismantlers and rebuilders to used car dealers and exporters.
What Makes CPRT Stand Out?
- Annual revenue growth of 13.4% over the past five years was outstanding, reflecting market share gains this cycle
- Robust free cash flow margin of 24.3% gives it many options for capital deployment, and its improved cash conversion implies it’s becoming a less capital-intensive business
- Stellar returns on capital showcase management’s ability to surface highly profitable business ventures
At $33.66 per share, Copart trades at 21x forward P/E. Is now the right time to buy? See for yourself in our full research report, it’s free.
Natera (NTRA)
Market Cap: $47.86 billion
Founded in 2003 as Gene Security Network before rebranding in 2012, Natera (NASDAQ: NTRA) develops and commercializes genetic tests for prenatal screening, cancer detection, and organ transplant monitoring using its proprietary cell-free DNA technology.
Why Do We Love NTRA?
- Average unit sales growth of 19.3% over the past two years reflects steady demand for its products
- Earnings per share grew by 18.2% annually over the last five years, massively outpacing its peers
- Free cash flow profile has moved into positive territory over the last five years, indicating the company has achieved financial self-sustainability
Natera’s stock price of $332.30 implies a valuation ratio of 14.9x forward price-to-sales. Is now a good time to buy? Find out in our full research report, it’s free.
Cigna (CI)
Market Cap: $73.33 billion
With roots dating back to 1792 and serving millions of customers across the globe, The Cigna Group (NYSE: CI) provides healthcare services through its Evernorth Health Services and Cigna Healthcare segments, offering pharmacy benefits, specialty care, and medical plans.
Why Are We Positive on CI?
- Annual revenue growth of 13.8% over the last two years beat the sector average and underscores the unique value of its offerings
- Massive revenue base of $282.1 billion gives it meaningful leverage when negotiating reimbursement rates
- Earnings growth has easily exceeded the peer group average over the last five years as its EPS has compounded at 12% annually
Cigna is trading at $277.06 per share, or 8.7x forward P/E. Is now the time to initiate a position? See for yourself in our comprehensive research report, it’s free.
Stocks We Like Even More
WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don’t just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.
But our AI platform says the party isn’t over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+214% between June 2020 and June 2025). Find your next big winner with StockStory today.
